Related Experiment Video
Updated: Oct 12, 2025

07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
7.0K
Mesothelioma Malignancy and the Microenvironment: Molecular Mechanisms
Francesca Cersosimo1, Marcella Barbarino2,3, Silvia Lonardi4
1Department of Biotechnology Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Cancers
|November 27, 2021
Summary
The tumor microenvironment (TME) is key in cancer. Understanding the malignant pleural mesothelioma microenvironment (MPM-ME) may reveal new therapeutic targets for this asbestos-related cancer.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- The tumor microenvironment (TME) significantly influences cancer initiation and progression.
- Malignant pleural mesothelioma (MPM), linked to asbestos exposure, has limited treatment options and poor prognosis.
- MPM is characterized by substantial leukocyte infiltration, particularly macrophages, creating a unique inflammatory milieu.
Purpose of the Study:
- To review the current understanding of the malignant pleural mesothelioma microenvironment (MPM-ME).
- To explore the role of cellular and soluble components within the MPM-ME.
- To identify potential molecular targets for improved mesothelioma therapies.
Main Methods:
- Literature review of studies on the MPM microenvironment.
- Analysis of cellular and soluble factors within the MPM-ME.
- Examination of intercellular communication networks in MPM.
Main Results:
- The MPM-ME involves complex crosstalk between tumor cells, stromal cells, and immune cells, notably macrophages.
- Accumulated macrophages in the pleural cavity contribute to inflammation and malignant transformation.
- Bidirectional communication within the MPM-ME supports tumor development and progression.
Conclusions:
- Characterizing the MPM-ME is crucial for understanding mesothelioma biology.
- The MPM-ME network offers potential druggable targets for novel therapeutic strategies.
- Further research into the MPM-ME could improve patient outcomes for malignant pleural mesothelioma.
Related Concept Videos
The Tumor Microenvironment
6.9K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.9K
Metastasis
5.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.8K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K

